Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
dc.contributor.author | Thompson, Mark G. | |
dc.contributor.author | Natarajan, Karthik | |
dc.contributor.author | Irving, Stephanie A. | |
dc.contributor.author | Rowley, Elizabeth A. | |
dc.contributor.author | Griggs, Eric P. | |
dc.contributor.author | Gaglani, Manjusha | |
dc.contributor.author | Klein, Nicola P. | |
dc.contributor.author | Grannis, Shaun J. | |
dc.contributor.author | DeSilva, Malini B. | |
dc.contributor.author | Stenehjem, Edward | |
dc.contributor.author | Reese, Sarah E. | |
dc.contributor.author | Dickerson, Monica | |
dc.contributor.author | Naleway, Allison L. | |
dc.contributor.author | Han, Jungmi | |
dc.contributor.author | Konatham, Deepika | |
dc.contributor.author | McEvoy, Charlene | |
dc.contributor.author | Rao, Suchitra | |
dc.contributor.author | Dixon, Brian E. | |
dc.contributor.author | Dascomb, Kristin | |
dc.contributor.author | Lewis, Ned | |
dc.contributor.author | Levy, Matthew E. | |
dc.contributor.author | Patel, Palak | |
dc.contributor.author | Liao, I-Chia | |
dc.contributor.author | Kharbanda, Anupam B. | |
dc.contributor.author | Barron, Michelle A. | |
dc.contributor.author | Fadel, William F. | |
dc.contributor.author | Grisel, Nancy | |
dc.contributor.author | Goddard, Kristin | |
dc.contributor.author | Yang, Duck-Hye | |
dc.contributor.author | Wondimu, Mehiret H. | |
dc.contributor.author | Murthy, Kempapura | |
dc.contributor.author | Valvi, Nimish R. | |
dc.contributor.author | Arndorfer, Julie | |
dc.contributor.author | Fireman, Bruce | |
dc.contributor.author | Dunne, Margaret M. | |
dc.contributor.author | Embi, Peter | |
dc.contributor.author | Azziz-Baumgartner, Eduardo | |
dc.contributor.author | Zerbo, Ousseny | |
dc.contributor.author | Bozio, Catherine H. | |
dc.contributor.author | Reynolds, Sue | |
dc.contributor.author | Ferdinands, Jill | |
dc.contributor.author | Williams, Jeremiah | |
dc.contributor.author | Link-Gelles, Ruth | |
dc.contributor.author | Schrag, Stephanie J. | |
dc.contributor.author | Verani, Jennifer R. | |
dc.contributor.author | Ball, Sarah | |
dc.contributor.author | Ong, Toan C. | |
dc.contributor.department | Family Medicine, School of Medicine | |
dc.date.accessioned | 2024-06-21T15:50:02Z | |
dc.date.available | 2024-06-21T15:50:02Z | |
dc.date.issued | 2022-01-28 | |
dc.identifier.citation | Thompson, M. G. (2022). Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance—VISION Network, 10 States, August 2021–January 2022. MMWR. Morbidity and Mortality Weekly Report, 71. https://doi.org/10.15585/mmwr.mm7104e3 | |
dc.identifier.uri | https://hdl.handle.net/1805/41747 | |
dc.language.iso | en_US | |
dc.publisher | U.S. Department of Health & Human Services | |
dc.relation.isversionof | 10.15585/mmwr.mm7104e3 | |
dc.relation.journal | Morbidity and Mortality Weekly Report | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | COVID-19 | |
dc.subject | mRNA | |
dc.subject | vaccine effectiveness (VE) | |
dc.subject | SARS-CoV-2 variants | |
dc.title | Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 | |
dc.type | Article |